Neurobehavior in preterm neonates exposed to cocaine, alcohol, and tobacco

Infant Behavior and Development

Volumn 20, Issue 3, 1997, Pages 297-309

  Espy, Kimberly Andrews ^a   Riese, Marilyn L ^b   Francis, David J ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Growth curve analysis; Neonatal; Prematurity neurobehavioral development; Prenatal alcohol exposure; Prenatal cocaine exposure

Indexed keywords

EID: 0031191903     PISSN: 01636383     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-6383(97)90002-3     Document Type: Article

References (40)

1. Als H., Gilkerson L. Developmentally supportive care in the neonatal intinsive care unit. Zero to Three. 15:1995;1-10.
2. Azuma S., Chasnoff I. Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three year data. Pediatrics. 92:1993;396-402.
3. Ballard J.L., Novak K.K., Driver M. A simplified score for assesment of fetal maturation of newly born infants. Journal of Pediatrics. 95:1979;769-774.
4. Bibb K.W., Stewart D.L., Walker J.R., Cook V.R., Wagener R.E. Drug screening in newborns and mothers using meconium samples, paired urine samples and interviews. Journal of Perinatalogy. 15:1995;199-202.
5. Brazelton T.B. Neonatal behavioral assessment scale. Clinics in Developmental Medicine. 2nd ed. 1984;Lippincott, Philadelphia. No. 88.
6. Brazelton T.B. Saving the bathwater. Child Development. 61:1990;1661-1671.
7. Brinker R.P., Baxter A., Butler L.S. An ordinal pattern analysis of four hypotheses describing interactions between drug-addicted, chronically disadvantaged, and middle-class mother - inf ant dyads. Child Development. 65:1994;361-372.
8. Bryk A.S., Raudenbush S.W. Application of hierarchical linear models to assessing change. Psychological Bulletin. 101:1987;147-158.
9. Caputo O.V., Mandell W. Consequences of low birth weight. Developmental Psychology. 3:1970;363-383.
10. Chasnoff I.J., Burns W.J., Schnoll S.H., Burns K.A. Cocaine use in pregnancy. New England Journal of Medicine. 313:1985;666-669.
11. Chasnoff I.J., Griffith D.R., MacGregor S., Dirkes K., Burns K.A. Temporal patterns of cocaine use in pregnancy. Journal of the American Medical Association. 261:1989;1741-1744.
12. Coles C.D., Platzman K.A., Smith I., James M.E., Falek A. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neorobehavioral status. Neurotoxicology and Teratology. 14:1992;23-33.
13. Diamond A. Guidelines for the study of brain-behavior relationships during development. Levin H.S., Eisenberg H.M., Benton A.L. Frontal lobe function and dysfunction. 1991;339-378 Oxford University Press, New York.
14. Eisen L.N., Field T.M., Bandstra E.S., Roberts J.P., Morrow C., Larson S.L., Steele B.M. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton scale. Pediatrics. 88:1991;477-480.
15. Francis D.J., Fletcher J.M., Steubing K.K., Davidson K.C., Thompson N.M. Analysis of change: Modeling individual growth. Journal of Consulting and Clinical Psychology. 59:1991;27-37.
16. Gillogley K.M., Evans A.T., Hansen R.L., Samuels S.T., Batra K.K. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. American Journal of Obstetrics and Gynecology. 163:1990;1535-1542.
17. Goldman P.S. Plasticity of function in the CNS. Stein D.G., Rosen J.J., Butters N. Plasticity and recovery of function in the central nervous system. 1974;149-174 Academic, London.
18. Hunter J.E., Schmidt F.L. Methods of meta-analysis: Correcting error and bias in research findings. 1990;Sage, Newbury Park, CA.
19. Jacobson S.W., Fein G.G., Jacobson J.L., Schwartz P.M., Dowler J.K. Neonatal correlates of prenatal exposure to smoking, caffeine and alcohol. Infant Behavior and Development. 7:1984;253-264.
20. Jessor R., Graves T.D., Hanson R.C., Jessor S.L. Society, Personality, and Deviant Behavior: A study of a Tri-ethnic community. 1968;Holt, Rhinehart & Winston, New York.
21. Korner A.F. The scope and limitations of neurologic and behavioral assessments of the newborn. Stevenson D.K., Sunshine P. Fetal and neonatal brain injury: Mechanisms, management, and the risks of practice. 1989;239-249 B.C. Decker, Toronto.
22. Korner A.F., Brown B.W., Dimiceli S., Forrest T., Stevenson D.K., Lane N.M., Constantino J. Stable individual differences in developmentally changing preterm infants: A replicated study. Child Development. 60:1989;502-513.
23. Korner A.F., Constantinou J., Dimiceli S., Brown B.W., Thom V.A. Establishing the reliability and developmental validity of a neurobehavioral assessment for preterm infants: A methodological process. Child Development. 62:1991;1200-1208.
24. Korner A.F., Kraemer H.C., Reade E.P., Forrest T., Dimiceli S. A methodological approach to developing an assessment procedure for testing the neurobehavioral maturity of preterm infants. Child Development. 58:1987;1478-1487.
25. Korner A.F., Thom V.A. Neurobehavioral assessment of the preterm infant manual. 1990;The Psychological Corporation, San Antonio, TX.
26. Kraemer H.C., Korner A.F., Hurwitz S. A model for assessing the development of preterm infants as a function of gestational, conceptional, or chronological age. Child Development. 21:1985;806-812.
27. Mayes L.C., Bornstein M.H. Developmental dilemmas for cocaine-abusing parents and their children. Lewis M., Bendersky M. Mothers, babies and cocaine: The role of toxins in development. 1995;251-272 Erlbaum, Hillsdale, NJ.
28. Mayes L.C., Granger R.H., Frank M.A., Schottenfeld R., Bornstein M.H. Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics. 91:1993;778-783.
29. McCall R.B. Challenges to a science of developmental psychology. Child Development. 48:1977;333-344.
30. Neuspiel D.R. The problem of confounding in research on prenatal cocaine effects on behavior and development. Lewis M., Bendersky M. Mothers, babies, and cocaine: The role of toxins in development. 1995;19-40 Erlbaum, Hillsdale, NJ.
31. Neuspiel D.R., Hamel S.C., Hochberg E., Greene J., Campbell D. Maternal cocaine use and infant behavior. Neurotoxicology and Teratology. 13:1991;229-233.
32. Rogosa D.R., Willet J.B. Understanding the correlates of change by modeling individual differences in growth. Psychometrika. 50:1985;203-228.
33. Rose S.A., Feldman J.F. Prediction of IQ and specific cognitive abilities at 11 years from infancy measures. Developmental Psychology. 31:1995;685-696.
34. Satz P., Fletcher J.M., Clark W., Morris R. Lag, deficit, rate and delay constructs in specific learning disabilities: A re-examination. Ansara A., et al. Sex differences in dyslexia. 1981;129-150 Orton Dyslexia Society, New York.
35. Saxon A.J., Calsyn D.A., Haver V.M., Delaney C.J. Clinical evaluation and use of urine screening for drug abuse. Western Journal of Medicine. 149:1988;296-303.
36. Streissguth A.P., Martin D.C., Buffington V.E. Test-retest reliability of three scales deriving from a quantity-frequency-variability assessment of self-report alcohol consumption. Annals of the New York Academy of Sciences. 273:1976;458-466.
37. Thompson N.M., Francis D.J., Steubing K.K., Fletcher J.M., Ewing-Cobbs L., Miner M.E., Levin H.S., Eisenberg H.M. Motor, visual-spatial and somatosensory skills after closed head injury in children and adolescents: A study of change. Neuropsychology. 8:1994;333-342.
38. Willett J.B. Questions and answers in the measurement of change. Rothkopf E.Z. Review of Research in Education. 15:1988;345-422.
39. Woods N.S., Eyler F.D., Behnke M., Conlon M. Cocaine use during pregnancy: Maternal depressive symptoms and infant neurobehavior over the first month. Infant Behavior and Development. 16:1993;83-98.
40. Woods N.S., Behnke M., Eyler F.D., Conlon M., Wobie K. Cocaine use among pregnant women: Socioeconomic, obstetrical, and psychological issues. Lewis M., Bendersky M. Mothers, babies, and cocaine: The role of toxins in development. 1995;305-332 Erlbaum, Hillsdale, NJ.